Bright Health Group, Inc. Accounts Receivables
| Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|
| Accounts Receivables | $0.0 | $787.0K | $60.5M | $113.5M | $172.8M | $0.0 |
Bright Health Group, Inc. (BHG) Accounts Receivables comparison analysis
General
LTM Accounts Receivables
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
BHG key stats
| Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|
% growth | 130.6 0.0% | 280.7 114.9% | 1,207.3 330.2% | 4,029.4 233.7% | 2,412.0 (40.1%) | 1,160.8 (51.9%) |
| Cost of Goods Sold (COGS) | 96.4 | 224.4 | 1,047.3 | 3,953.7 | 2,206.2 | 1,283.7 |
% margin | 34.2 26.2% | 56.3 20.1% | 160.0 13.3% | 75.7 1.9% | 205.8 8.5% | (122.9) (10.6%) |
| Operating Expenses | 96.9 | 181.6 | 417.6 | 1,273.9 | 682.5 | 1,737.8 |
| Research & Development Expenses (R&D) | 2.5 | 7.2 | 19.4 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 81.2 | 153.9 | 308.7 | 914.1 | 584.2 | 0.0 |
% margin | (62.6) (48.0%) | (125.3) (44.7%) | (257.6) (21.3%) | (1,198.2) (29.7%) | (476.7) (19.8%) | (627.7) (54.1%) |
| Interest Income | 0.0 | 0.0 | 0.0 | 7.2 | 12.8 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 8.0 | 12.8 | 38.2 |
| Pre-tax Income | (62.6) | (125.3) | (257.6) | (1,204.9) | (634.3) | (629.2) |
% effective tax rate | 3.5 (5.6%) | 8.4 (6.7%) | (9.2) 3.6% | (26.5) 2.2% | 3.7 (0.6%) | (1.4) 0.2% |
% margin | (62.6) (48.0%) | (133.7) (47.6%) | (248.4) (20.6%) | (1,178.4) (29.2%) | (638.0) (26.4%) | (1,200.6) (103.4%) |
| EPS | (37.97) | (79.52) | (145.94) | (240.33) | (81.08) | (150.94) |
| Diluted EPS | (37.97) | (79.52) | (145.94) | (240.33) | (81.08) | (150.94) |
% margin | (61.6) (47.2%) | (124.2) (44.3%) | (249.3) (20.7%) | (1,161.4) (28.8%) | (425.3) (17.6%) | (1,145.5) (98.7%) |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Bright Health Group, Inc.'s Accounts Receivables?
As of today, Bright Health Group, Inc.'s last 12-month Accounts Receivables is $39.1M, based on the financial report for Dec 31, 2023 (Q4’2023).
2) What is Bright Health Group, Inc.'s Accounts Receivables growth rate?
Over the last year, Bright Health Group, Inc.'s Accounts Receivables growth was (77.4%). The average annual Accounts Receivables growth rates for Bright Health Group, Inc. have been N/A over the past three years, N/A over the past five years.
3) Is Bright Health Group, Inc.'s Accounts Receivables growth rate Good?
Over the last year, Bright Health Group, Inc.'s Accounts Receivables growth was (77.4%), which is lower than industry growth of (0.3%). It indicates that Bright Health Group, Inc.'s Accounts Receivables growth is Good.